Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Peptide-based therapeutic cancer vaccine: Current trends in clinical application.
Cell Prolif. 2021 May;54(5):e13025. doi: 10.1111/cpr.13025. Epub 2021 Mar 22.
Cell Prolif. 2021.
PMID: 33754407
Free PMC article.
Review.
Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M, Wu H, Jiang Q, Liu Y, Han L, Yan Y, Wei B, Liu F, Deng X, Chen H, Zhao L, Wang M, Wu X, Yao W, Zhao H, Chen J, Wei M.
He M, et al.
Mol Oncol. 2019 Feb;13(2):403-421. doi: 10.1002/1878-0261.12419. Epub 2019 Jan 14.
Mol Oncol. 2019.
PMID: 30536571
Free PMC article.
OVCAR-3 and CAOV-3 sphere-forming (OVCAR-3 S and CAOV-3 S) cells with OCSC-like properties showed strong resistance to adriamycin (ADR). ...Knockdown of HIF-2alpha expression substantially attenuated the resistance of OVCAR-3 S and CAOV-3 S cells to AD …
OVCAR-3 and CAOV-3 sphere-forming (OVCAR-3 S and CAOV-3 S) cells with OCSC-like properties showed strong resistance to adriamy …
Item in Clipboard
HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y, Liu F, Han L, Zhao L, Chen J, Olopade OI, He M, Wei M.
Yan Y, et al.
J Exp Clin Cancer Res. 2018 Oct 19;37(1):256. doi: 10.1186/s13046-018-0925-x.
J Exp Clin Cancer Res. 2018.
PMID: 30340507
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.